Dr. Amy Abernethy(@DrAbernethyFDA) 's Twitter Profileg
Dr. Amy Abernethy

@DrAbernethyFDA

Former Principal Deputy Commissioner and Acting CIO at @US_FDA. This account is now archived.

ID:1109068098118840322

linkhttps://www.fda.gov calendar_today22-03-2019 12:23:34

345 Tweets

7,4K Followers

73 Following

Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO(@tomleblancMD) 's Twitter Profile Photo

'Data empathy' - an overdue concept in and work. Below is essential reading on key considerations in data/inquiries. Credit to Dr. Amy Abernethy, mentioned herein, who taught us data empathy years ago Duke Cancer timmermanreport.com/2021/01/whats-…

account_circle
Dr. Janet Woodcock(@DrWoodcockFDA) 's Twitter Profile Photo

By unleashing the power of real-world evidence, we can accelerate medical product development and bring new innovations and advances faster and more efficiently to the patients who need them, without compromising patient safety. go.usa.gov/xsGzE

account_circle
Dr. Janet Woodcock(@DrWoodcockFDA) 's Twitter Profile Photo

Our new Data Modernization Action Plan is great news for the agency, public health and our stakeholders & it’s the next step in FDA’s overhaul of its approach to technology and data. go.usa.gov/xsn8v

account_circle
Dr. Amy Abernethy(@DrAbernethyFDA) 's Twitter Profile Photo

FDA’s Data Modernization Action Plan leverages the foundations laid by our Technology Modernization Action Plan: a modern, cloud-forward technical infrastructure; a product-oriented approach and enhanced collaboration. go.usa.gov/xsn8v

account_circle
Dr. Amy Abernethy(@DrAbernethyFDA) 's Twitter Profile Photo

FDA is focused on data & tech modernization that supports real-time analyses to inform regulatory work. E.g., yesterday we launched part 2 of a pilot to use AI to enhance our ability to identify violative imported seafood products ('stinky fish'). fda.gov/news-events/fd…

account_circle
Dr. Janet Woodcock(@DrWoodcockFDA) 's Twitter Profile Photo

FDA has completed our investigation of the 2020 leafy greens E.coli outbreak. We found the presence of a recurring strain of E. coli in the growing region, which could serve as a potential source associated with future contamination events. go.usa.gov/xA6TD

FDA has completed our investigation of the 2020 leafy greens E.coli outbreak. We found the presence of a recurring strain of E. coli in the growing region, which could serve as a potential source associated with future contamination events. go.usa.gov/xA6TD
account_circle
Dr. Janet Woodcock(@DrWoodcockFDA) 's Twitter Profile Photo

Producing or distributing drugs that don’t meet FDA quality standards poses a serious risk of harm to patients. This will not be tolerated. Compounders should know their bulk drug substance or API supplier in case quality concerns arise.

account_circle
Dr. Amy Abernethy(@DrAbernethyFDA) 's Twitter Profile Photo

National Library of Medicine's Pubmed, released in 1996, is a great example of how government action accelerates progress. Pubmed made searching the medical literature easy and free - a catalytic event in the application of research-based evidence to patient care. Friends of the NLM

account_circle